APOE and Alzheimer disease: Additionally, human APOE4 carriers exhibit increased cerebral spinal fluid MMP-9 expression, correlating with enhanced BBB dysfunction [21], while APOE4 post-mortem AD brains have increased CypA and MMP-9 in cortical pericytes [22].